The Cell Biology & Assay Development team uses a variety of cell lines and tools to execute a range of bespoke assays that generate data with machine learning models in mind. Our scientists work with a range of cell types and proteins to develop tumour and immune cell screening assays to discover and characterise complex multi-specific antibodies.
Recent projects include screening assays to investigate T cell activation, immune cell mediated cytotoxicity, cancer cell proliferation, tumour cell receptor internalisation, antibody binding and cell line engineering.
We are growing fast and would love to hear from you if you're interested in joining the team.
About LabGenius
Headquartered in London, LabGenius Therapeutics is a leading machine learning-driven protein engineering company. The company’s core technology platform, EVA™, enables the rapid discovery of novel therapeutic antibodies. LabGenius’ highly multidisciplinary team brings together the very best minds from the fields of computer science, robotic automation and synthetic biology.
Already working at LabGenius?
Let’s recruit together and find your next colleague.